Syneron Candela and Allergan Reward Loyal Customers

Earlier this year, Syneron Medical, a leading global aesthetic device company, and Allergan, pharmaceutical company and manufacturer of Botox, announced a collaboration to offer three of Syneron Candela’s body sculpting and skincare platforms to members of Allergan’s healthcare provider loyalty program, Allergan Partner Privileges (APP). “This partnership brings together two very strong aesthetics product portfolios to provide physicians and their patients with comprehensive treatment options for some of the most in-demand treatments, including body contouring and skin treatment,” says Amit Meridor, CEO of Syneron Medical. “We are excited to partner with Allergan to introduce our products to Allergan’s community of aesthetic healthcare providers and their patients. In addition, at a strategic level, this partnership will enhance our ability to build stronger relationships with our customers, supported by a full product solution offering.”

The partnership grants all members of APP discounted pricing on Syneron’s UltraShape and VelaShape III platforms for body contouring and the PicoWay platform for skin treatment. Says Philippe Schaison, executive vice president and president of Allergan Medical, “This collaboration complements our existing portfolio of industry-leading aesthetic products and further demonstrates Allergan’s commitment to providing our customers with a robust portfolio of treatments designed to better address their evolving patient needs.” The companies also plan to launch an additional consumer program later this year.

Suggested Articles

Dermatologists are the leading influencers for cosmetic procedures and skincare choices.

Unrealistic expectations of self-image driven by social media lead to disappointed clients.

The FDA granted Erchonia 510(k) market clearance to market its EVRL for the temporary relief of chronic neck and shoulder pain.